Published in Cancer Weekly, August 12th, 2008
Established in 1963, Taiho Pharmaceutical is a developer focused on oncology, allergy, immunology and urology therapies. In March 2008, Taiho made the decision to evaluate a large number of EDC providers. After a rigorous vendor selection process,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.